drugset / Press release
Syndax And Merck Announce First Patients Dosed In Phase 1b/2 Clinical Trial Of Entinostat And Keytruda®
2015-09-28 · Syndax Pharmaceuticals · original syndax.com ↗
Syndax And Merck Announce First Patients Dosed In Phase 1b/2 Clinical Trial Of Entinostat And Keytruda<font size="-1"><sup>®</sup></font>
The release as fetched from its publisher. syndax.com ↗